Market Tracker

12/18 4:17am ET

Dynavax Technologies Corp (NASDAQ:DVAX)

--
Data as of --
-- -- / --
Today’s Change
12.50
Today|||52-Week Range
21.40
--
Year-to-Date

Today’s Trading

Previous close15.12
Today’s open--
Day’s range-- - --
Volume4,184
Average volume (3 months)--
Market cap$377.0M
Dividend yield--
Data as of --

Growth & Valuation

Earnings growth (last year)+7.32%
Earnings growth (this year)-0.11%
Earnings growth (next 5 years)--
Revenue growth (last year)+15.82%
P/E ratioNM
Price/Sales34.19
Price/Book2.02

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc----
SUPNSupernus Pharmaceuti...+0.02+0.23%
IMDZImmune Design Corp----
RVNCRevance Therapeutics...+0.49+2.98%
Data as of 12/17/2014

Financials

Next reporting dateMarch 3, 2015
EPS forecast (this quarter)-$0.97
Annual revenue (last year)$11.3M
Annual profit (last year)-$66.7M
Net profit margin-593.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts